Back to Search
Start Over
Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay.
- Source :
-
Annals of Oncology . Nov2022, Vol. 33 Issue 11, p1204-1206. 3p. - Publication Year :
- 2022
- Subjects :
- *IMMUNE checkpoint proteins
*TUMORS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Issue :
- 11
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159846581
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.009